Skip to main content
. 2013 Feb 20;8(2):e56718. doi: 10.1371/journal.pone.0056718

Table 2. Demographic and clinical features of the AML and normal subjects.

Training Set Validation Set Training Set Validation Set
Variable Norm AML Norm AML Variable Norm AML Norm AML
Age (mean±SD) 47.18±15.24 51.42±16.31 51.45±17.54 47.90±15.23 CD2
<47 18 28 56 48 Negative 28 81
≥47 22 17 39 47 Positive 17 14
Gender CD5
Male 20 24 45 58 Negative 41 90
Female 20 21 40 37 Positive 4 5
Hemoglobin CD7
Male Negative 28 79
<120 0 24 0 53 Positive 17 16
≥120 20 0 45 5 CD10
Female Negative 45 91
<110 0 21 0 35 Positive 0 4
≥110 20 1 40 2 CD13
White blood cell Negative 1 6
<4.0 0 17 0 40 Positive 44 89
4.0–10.0 40 6 95 14 CD14
>10.0 0 22 0 41 Negative 30 65
Platelet Positive 15 30
<100 0 44 0 85 CD19
100–300 38 1 95 8 Negative 35 78
>300 2 0 0 2 Positive 10 17
FAB Classification CD22
M1 5 14 Negative 39 87
M2 13 33 Positive 6 8
M3 8 9 CD33
M4 8 10 Negative 0 5
M5 11 29 Positive 45 90
LDH CD34
≤245 17 39 Negative 14 30
>245 28 56 Positive 31 65